AI And Collaborations Will Transform Diagnostic Testing

AN
AnalystConsensusTarget
Consensus Narrative from 17 Analysts
Published
08 Aug 24
Updated
06 Aug 25
AnalystConsensusTarget's Fair Value
US$291.65
10.9% undervalued intrinsic discount
06 Aug
US$259.96
Loading
1Y
15.7%
7D
-0.05%

Author's Valuation

US$291.6

10.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Increased 7.96%

Shared on30 Apr 25
Fair value Increased 0.093%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 0.40%

AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.

Shared on16 Apr 25
Fair value Decreased 1.11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 0.026%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 1.30%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 3.09%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Increased 0.50%